Literature DB >> 20346862

AHRQ series commentary 3: the United States addresses comparative effectiveness but not cost-effectiveness through the effective health-care program.

Nick Freemantle1, Michael F Drummond.   

Abstract

Mesh:

Year:  2010        PMID: 20346862     DOI: 10.1016/j.jclinepi.2010.01.008

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


× No keyword cloud information.
  2 in total

1.  Novel approaches to incorporating pharmacoeconomic studies into phase III clinical trials for Alzheimer's disease.

Authors:  H Fillit; J Cummings; P Neumann; T McLaughlin; P Salavtore; C Leibman
Journal:  J Nutr Health Aging       Date:  2010-10       Impact factor: 4.075

2.  Balancing influence between actors in healthcare decision making.

Authors:  Robert M Kaplan; Yair M Babad
Journal:  BMC Health Serv Res       Date:  2011-04-19       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.